{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:27:43Z","timestamp":1794580063077,"version":"4.9.1"},"reference-count":256,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02520-6","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:26:54Z","timestamp":1764584814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Ferroptosis in cancer: metabolism, mechanisms and therapeutic prospects"],"prefix":"10.1186","volume":"24","author":[{"given":"Yansheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuansheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2520_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"2520_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/humupd\/dmad005","volume":"29","author":"JM Stringer","year":"2023","unstructured":"Stringer JM, Alesi LR, Winship AL, Hutt KJ. Beyond apoptosis: evidence of other regulated cell death pathways in the ovary throughout development and life. Hum Reprod Update. 2023;29:434\u201356.","journal-title":"Hum Reprod Update"},{"key":"2520_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"19","author":"I Dikic","year":"2018","unstructured":"Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19:349\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2520_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187:235\u201356.","journal-title":"Cell"},{"key":"2520_CR5","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"2520_CR6","doi-asserted-by":"crossref","unstructured":"Dai E, et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat Cell Biol. 2024;26(9):1447\u20131457.","DOI":"10.1038\/s41556-024-01360-8"},{"key":"2520_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2520_CR8","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41556-020-0565-1","volume":"22","author":"M Riegman","year":"2020","unstructured":"Riegman M, et al. Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture. Nat Cell Biol. 2020;22:1042\u20138.","journal-title":"Nat Cell Biol"},{"key":"2520_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59:298\u2013308.","journal-title":"Mol Cell"},{"key":"2520_CR10","doi-asserted-by":"crossref","unstructured":"Rochette L, et al. Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci. 2022;24(1):449.","DOI":"10.3390\/ijms24010449"},{"key":"2520_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/jcp.2010.079046","volume":"64","author":"M Munoz","year":"2011","unstructured":"Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. J Clin Pathol. 2011;64:281\u20136.","journal-title":"J Clin Pathol"},{"key":"2520_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.redox.2017.11.026","volume":"15","author":"N DeGregorio-Rocasolano","year":"2018","unstructured":"DeGregorio-Rocasolano N, Marti-Sistac O, Ponce J, et al. Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage. Redox Biol. 2018;15:143\u201358.","journal-title":"Redox Biol"},{"key":"2520_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2018.07.020","volume":"133","author":"I Yanatori","year":"2019","unstructured":"Yanatori I, Kishi F. DMT1 and iron transport. Free Radic Biol Med. 2019;133:55\u201363.","journal-title":"Free Radic Biol Med"},{"key":"2520_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Y Zou","year":"2020","unstructured":"Zou Y, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16:302\u20139.","journal-title":"Nat Chem Biol"},{"key":"2520_CR15","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.biocel.2011.08.016","volume":"43","author":"T Kurz","year":"2011","unstructured":"Kurz T, Eaton JW, Brunk UT. The role of lysosomes in iron metabolism and recycling. Int J Biochem Cell Biol. 2011;43:1686\u201397.","journal-title":"Int J Biochem Cell Biol"},{"key":"2520_CR16","doi-asserted-by":"crossref","unstructured":"Gensluckner S, Wernly B, Datz C, Aigner E. Iron, Oxidative Stress, and metabolic Dysfunction-Associated steatotic liver disease. Antioxid (Basel). 2024;13(2):208","DOI":"10.3390\/antiox13020208"},{"key":"2520_CR17","doi-asserted-by":"crossref","unstructured":"Huang L, Bian M, Zhang J, Jiang L. Iron Metabolism and Ferroptosis in Peripheral Nerve Injury. Oxid Med Cell Longev. 2022;2022:5918218.","DOI":"10.1155\/2022\/5918218"},{"key":"2520_CR18","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1021\/cb300323q","volume":"7","author":"PA Frey","year":"2012","unstructured":"Frey PA, Reed GH. The ubiquity of iron. ACS Chem Biol. 2012;7:1477\u201381.","journal-title":"ACS Chem Biol"},{"key":"2520_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-pathol-012513-104651","volume":"9","author":"JD Lambeth","year":"2014","unstructured":"Lambeth JD, Neish AS. Nox enzymes and new thinking on reactive oxygen: a double-edged sword revisited. Annu Rev Pathol. 2014;9:119\u201345.","journal-title":"Annu Rev Pathol"},{"key":"2520_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.bbamcr.2015.01.021","volume":"1853","author":"DJ Lane","year":"2015","unstructured":"Lane DJ, et al. Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease. Biochim Biophys Acta. 2015;1853:1130\u201344.","journal-title":"Biochim Biophys Acta"},{"key":"2520_CR21","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.7150\/thno.59092","volume":"11","author":"M Morales","year":"2021","unstructured":"Morales M, Xue X. Targeting iron metabolism in cancer therapy. Theranostics. 2021;11:8412\u201329.","journal-title":"Theranostics"},{"key":"2520_CR22","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/cas.15250","volume":"113","author":"L Lin","year":"2022","unstructured":"Lin L, Chen H, Zhao R, Zhu M, Nie G. Nanomedicine targets iron metabolism for cancer therapy. Cancer Sci. 2022;113:828\u201337.","journal-title":"Cancer Sci"},{"key":"2520_CR23","doi-asserted-by":"publisher","first-page":"17667","DOI":"10.1038\/s41598-017-17804-1","volume":"7","author":"C Raggi","year":"2017","unstructured":"Raggi C, et al. Dysregulation of iron metabolism in cholangiocarcinoma Stem-like cells. Sci Rep. 2017;7:17667.","journal-title":"Sci Rep"},{"key":"2520_CR24","first-page":"916","volume":"8","author":"Y Shen","year":"2018","unstructured":"Shen Y, et al. Transferrin receptor 1 in cancer: a new sight for cancer therapy. Am J Cancer Res. 2018;8:916\u201331.","journal-title":"Am J Cancer Res"},{"key":"2520_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nrm2256","volume":"8","author":"B D\u2019Autr\u00e9aux","year":"2007","unstructured":"D\u2019Autr\u00e9aux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 2007;8:813\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2520_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","volume":"80","author":"JN Moloney","year":"2018","unstructured":"Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50\u201364.","journal-title":"Semin Cell Dev Biol"},{"key":"2520_CR27","doi-asserted-by":"crossref","unstructured":"Chiang SK, Chen SE, Chang LC. A dual role of Heme Oxygenase-1 in cancer cells. Int J Mol Sci. 2018;20(1):39.","DOI":"10.3390\/ijms20010039"},{"key":"2520_CR28","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan Y, et al. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat Commun. 2023;14:3673.","journal-title":"Nat Commun"},{"key":"2520_CR29","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.7150\/ijbs.80735","volume":"19","author":"L Sanguigno","year":"2023","unstructured":"Sanguigno L, et al. Stroke by inducing HDAC9-dependent deacetylation of HIF-1 and Sp1, promotes TfR1 transcription and GPX4 reduction, thus determining ferroptotic neuronal death. Int J Biol Sci. 2023;19:2695\u2013710.","journal-title":"Int J Biol Sci"},{"key":"2520_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41418-022-01089-7","volume":"30","author":"D Wang","year":"2023","unstructured":"Wang D, et al. SPY1 inhibits neuronal ferroptosis in amyotrophic lateral sclerosis by reducing lipid peroxidation through regulation of GCH1 and TFR1. Cell Death Differ. 2023;30:369\u201382.","journal-title":"Cell Death Differ"},{"key":"2520_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/ars.2017.7063","volume":"30","author":"Q Wu","year":"2019","unstructured":"Wu Q, et al. Mitochondrial ferritin is a Hypoxia-Inducible factor 1\u03b1-Inducible gene that protects from Hypoxia-Induced cell death in brain. Antioxid Redox Signal. 2019;30:198\u2013212.","journal-title":"Antioxid Redox Signal"},{"key":"2520_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrm.2017.138","volume":"19","author":"T Harayama","year":"2018","unstructured":"Harayama T, Riezman H. Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol. 2018;19:281\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2520_CR33","doi-asserted-by":"publisher","first-page":"e2100396","DOI":"10.1002\/adbi.202100396","volume":"5","author":"Z Lin","year":"2021","unstructured":"Lin Z, Liu J, Kang R, Yang M, Tang D. Lipid metabolism in ferroptosis. Adv Biol (Weinh). 2021;5:e2100396.","journal-title":"Adv Biol (Weinh)"},{"key":"2520_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.plipres.2016.02.001","volume":"62","author":"T Kimura","year":"2016","unstructured":"Kimura T, Jennings W, Epand RM. Roles of specific lipid species in the cell and their molecular mechanism. Prog Lipid Res. 2016;62:75\u201392.","journal-title":"Prog Lipid Res"},{"key":"2520_CR35","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","volume":"100","author":"T Mashima","year":"2009","unstructured":"Mashima T, Seimiya H, Tsuruo T. De Novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer. 2009;100:1369\u201372.","journal-title":"Br J Cancer"},{"key":"2520_CR36","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1038\/s41467-022-31963-4","volume":"13","author":"C Bartolacci","year":"2022","unstructured":"Bartolacci C, et al. Targeting de Novo lipogenesis and the lands cycle induces ferroptosis in KRAS-mutant lung cancer. Nat Commun. 2022;13:4327.","journal-title":"Nat Commun"},{"key":"2520_CR37","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82:2215\u201327.","journal-title":"Mol Cell"},{"key":"2520_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390.","journal-title":"Nat Chem Biol"},{"key":"2520_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong L, et al. Exogenous monounsaturated fatty acids promote a Ferroptosis-Resistant cell state. Cell Chem Biol. 2019;26:420\u2013e432429.","journal-title":"Cell Chem Biol"},{"key":"2520_CR40","doi-asserted-by":"publisher","first-page":"149167","DOI":"10.1016\/j.bbrc.2023.149167","volume":"687","author":"NT Moldogazieva","year":"2023","unstructured":"Moldogazieva NT, Zavadskiy SP, Astakhov DV, Terentiev AA. Lipid peroxidation: reactive carbonyl species, protein\/DNA adducts, and signaling switches in oxidative stress and cancer. Biochem Biophys Res Commun. 2023;687:149167.","journal-title":"Biochem Biophys Res Commun"},{"key":"2520_CR41","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/cr200084z","volume":"111","author":"H Yin","year":"2011","unstructured":"Yin H, Xu L, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev. 2011;111:5944\u201372.","journal-title":"Chem Rev"},{"key":"2520_CR42","doi-asserted-by":"crossref","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.","DOI":"10.1155\/2014\/360438"},{"key":"2520_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2018.09.008","volume":"133","author":"DA Stoyanovsky","year":"2019","unstructured":"Stoyanovsky DA, et al. Iron catalysis of lipid peroxidation in ferroptosis: regulated enzymatic or random free radical reaction? Free Radic Biol Med. 2019;133:153\u201361.","journal-title":"Free Radic Biol Med"},{"key":"2520_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017;482:419\u201325.","journal-title":"Biochem Biophys Res Commun"},{"key":"2520_CR45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2015.08.006","volume":"6","author":"R Mashima","year":"2015","unstructured":"Mashima R, Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol. 2015;6:297\u2013310.","journal-title":"Redox Biol"},{"key":"2520_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1389450118666170125144557","volume":"19","author":"P Manikandan","year":"2018","unstructured":"Manikandan P, Nagini S. Cytochrome P450 Structure, function and clinical significance: A review. Curr Drug Targets. 2018;19:38\u201354.","journal-title":"Curr Drug Targets"},{"key":"2520_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","volume":"81","author":"B Yan","year":"2021","unstructured":"Yan B, et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell. 2021;81:355\u2013e369310.","journal-title":"Mol Cell"},{"key":"2520_CR48","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42:513\u201334.","journal-title":"Cancer Cell"},{"key":"2520_CR49","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"M Conrad","year":"2019","unstructured":"Conrad M, Pratt DA. The chemical basis of ferroptosis. Nat Chem Biol. 2019;15:1137\u201347.","journal-title":"Nat Chem Biol"},{"key":"2520_CR50","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41574-023-00845-0","volume":"19","author":"A Zadoorian","year":"2023","unstructured":"Zadoorian A, Du X, Yang H. Lipid droplet biogenesis and functions in health and disease. Nat Rev Endocrinol. 2023;19:443\u201359.","journal-title":"Nat Rev Endocrinol"},{"key":"2520_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/112_2020_51","volume":"185","author":"T Petan","year":"2023","unstructured":"Petan T. Lipid droplets in cancer. Rev Physiol Biochem Pharmacol. 2023;185:53\u201386.","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"2520_CR52","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41556-024-01364-4","volume":"26","author":"AJ Mathiowetz","year":"2024","unstructured":"Mathiowetz AJ, Olzmann JA. Lipid droplets and cellular lipid flux. Nat Cell Biol. 2024;26:331\u201345.","journal-title":"Nat Cell Biol"},{"key":"2520_CR53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","volume":"20","author":"JA Olzmann","year":"2019","unstructured":"Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol. 2019;20:137\u201355.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2520_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.freeradbiomed.2014.07.042","volume":"76","author":"D Mohammadyani","year":"2014","unstructured":"Mohammadyani D, et al. Molecular speciation and dynamics of oxidized triacylglycerols in lipid droplets: mass spectrometry and coarse-grained simulations. Free Radic Biol Med. 2014;76:53\u201360.","journal-title":"Free Radic Biol Med"},{"key":"2520_CR55","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1038\/s41467-021-22471-y","volume":"12","author":"A Beatty","year":"2021","unstructured":"Beatty A, et al. Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1. Nat Commun. 2021;12:2244.","journal-title":"Nat Commun"},{"key":"2520_CR56","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.bbrc.2018.12.039","volume":"508","author":"Y Bai","year":"2019","unstructured":"Bai Y, et al. Lipid storage and lipophagy regulates ferroptosis. Biochem Biophys Res Commun. 2019;508:997\u20131003.","journal-title":"Biochem Biophys Res Commun"},{"key":"2520_CR57","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","volume":"33","author":"E Dierge","year":"2021","unstructured":"Dierge E, et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021;33:1701\u2013e17151705.","journal-title":"Cell Metab"},{"key":"2520_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41467-023-44412-7","volume":"15","author":"H Lee","year":"2024","unstructured":"Lee H, et al. Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. Nat Commun. 2024;15:79.","journal-title":"Nat Commun"},{"key":"2520_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/ars.2023.0278","volume":"39","author":"N Naowarojna","year":"2023","unstructured":"Naowarojna N, et al. Dynamic regulation of ferroptosis by lipid metabolism. Antioxid Redox Signal. 2023;39:59\u201378.","journal-title":"Antioxid Redox Signal"},{"key":"2520_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","volume":"38","author":"JPF Angeli","year":"2017","unstructured":"Angeli JPF, Shah R, Pratt DA, Conrad M. Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol Sci. 2017;38:489\u201398.","journal-title":"Trends Pharmacol Sci"},{"key":"2520_CR61","doi-asserted-by":"publisher","first-page":"102066","DOI":"10.1016\/j.arr.2023.102066","volume":"92","author":"D Lapenna","year":"2023","unstructured":"Lapenna D. Glutathione and glutathione-dependent enzymes: from biochemistry to gerontology and successful aging. Ageing Res Rev. 2023;92:102066.","journal-title":"Ageing Res Rev"},{"key":"2520_CR62","doi-asserted-by":"crossref","unstructured":"Combs JA, DeNicola GM. The Non-Essential amino acid cysteine becomes essential for tumor proliferation and survival. Cancers (Basel). 2019;11(5):678.","DOI":"10.3390\/cancers11050678"},{"key":"2520_CR63","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.bbamcr.2017.03.004","volume":"1864","author":"J Perez-Miguelsanz","year":"2017","unstructured":"Perez-Miguelsanz J, et al. Betaine homocysteine S-methyltransferase emerges as a new player of the nuclear methionine cycle. Biochim Biophys Acta Mol Cell Res. 2017;1864:1165\u201382.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2520_CR64","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.molmed.2017.03.004","volume":"23","author":"IIC Chio","year":"2017","unstructured":"Chio IIC, Tuveson DA. ROS in cancer: the burning question. Trends Mol Med. 2017;23:411\u201329.","journal-title":"Trends Mol Med"},{"key":"2520_CR65","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2020.12.007","volume":"33","author":"YP Kang","year":"2021","unstructured":"Kang YP, et al. Non-canonical Glutamate-Cysteine ligase activity protects against ferroptosis. Cell Metab. 2021;33:174\u2013e189177.","journal-title":"Cell Metab"},{"key":"2520_CR66","doi-asserted-by":"publisher","first-page":"eaax8358","DOI":"10.1126\/sciadv.aax8358","volume":"6","author":"E Doka","year":"2020","unstructured":"Doka E, et al. Control of protein function through oxidation and reduction of persulfidated States. Sci Adv. 2020;6:eaax8358.","journal-title":"Sci Adv"},{"key":"2520_CR67","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41416-020-01156-1","volume":"124","author":"VDB Bonifacio","year":"2021","unstructured":"Bonifacio VDB, Pereira SA, Serpa J, Vicente JB. Cysteine metabolic circuitries: druggable targets in cancer. Br J Cancer. 2021;124:862\u201379.","journal-title":"Br J Cancer"},{"key":"2520_CR68","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/bph.14464","volume":"176","author":"JB Kohl","year":"2019","unstructured":"Kohl JB, Mellis AT, Schwarz G. Homeostatic impact of sulfite and hydrogen sulfide on cysteine catabolism. Br J Pharmacol. 2019;176:554\u201370.","journal-title":"Br J Pharmacol"},{"key":"2520_CR69","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00726-017-2412-7","volume":"49","author":"MM Adeva-Andany","year":"2017","unstructured":"Adeva-Andany MM, Lopez-Maside L, Donapetry-Garcia C, Fernandez-Fernandez C, Sixto-Leal C. Enzymes involved in branched-chain amino acid metabolism in humans. Amino Acids. 2017;49:1005\u201328.","journal-title":"Amino Acids"},{"key":"2520_CR70","doi-asserted-by":"crossref","unstructured":"Kang YP, et al. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer. Elife. 2019;8:e45572.","DOI":"10.7554\/eLife.52671"},{"key":"2520_CR71","doi-asserted-by":"publisher","first-page":"116103","DOI":"10.1016\/j.bcp.2024.116103","volume":"222","author":"J Chen","year":"2024","unstructured":"Chen J, et al. Deletion of hepatocyte cysteine dioxygenase type 1, a bile acid repressed gene, enhances glutathione synthesis and ameliorates acetaminophen hepatotoxicity. Biochem Pharmacol. 2024;222:116103.","journal-title":"Biochem Pharmacol"},{"key":"2520_CR72","doi-asserted-by":"crossref","unstructured":"Sawa T, Motohashi H, Ihara H, Akaike T. Enzymatic regulation and biological functions of reactive cysteine persulfides and polysulfides. Biomolecules. 2020;10(9):1245.","DOI":"10.3390\/biom10091245"},{"key":"2520_CR73","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, DeBerardinis RJ. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168:657\u201369.","journal-title":"Cell"},{"key":"2520_CR74","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2520_CR75","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","volume":"593","author":"BI Reinfeld","year":"2021","unstructured":"Reinfeld BI, et al. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature. 2021;593:282\u20138.","journal-title":"Nature"},{"key":"2520_CR76","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang J, Pavlova NN, Thompson CB. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 2017;36:1302\u201315.","journal-title":"EMBO J"},{"key":"2520_CR77","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.celrep.2019.09.056","volume":"29","author":"AJ Bott","year":"2019","unstructured":"Bott AJ, et al. Glutamine anabolism plays a critical role in pancreatic cancer by coupling carbon and nitrogen metabolism. Cell Rep. 2019;29:1287\u2013e12981286.","journal-title":"Cell Rep"},{"key":"2520_CR78","doi-asserted-by":"publisher","first-page":"603837","DOI":"10.3389\/fcell.2020.603837","volume":"8","author":"Z Wei","year":"2020","unstructured":"Wei Z, Liu X, Cheng C, Yu W, Yi P. Metabolism of amino acids in cancer. Front Cell Dev Biol. 2020;8:603837.","journal-title":"Front Cell Dev Biol"},{"key":"2520_CR79","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.7150\/ijbs.64982","volume":"18","author":"J Yang","year":"2022","unstructured":"Yang J, Dai X, Xu H, Tang Q, Bi F. Regulation of ferroptosis by amino acid metabolism in cancer. Int J Biol Sci. 2022;18:1695\u2013705.","journal-title":"Int J Biol Sci"},{"key":"2520_CR80","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Yu YC, Sung Y, Han JM. Glutamine reliance in cell metabolism. Exp Mol Med. 2020;52:1496\u2013516.","journal-title":"Exp Mol Med"},{"key":"2520_CR81","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","volume":"19","author":"L Yang","year":"2017","unstructured":"Yang L, Venneti S, Nagrath D, Glutaminolysis. A hallmark of cancer metabolism. Annu Rev Biomed Eng. 2017;19:163\u201394.","journal-title":"Annu Rev Biomed Eng"},{"key":"2520_CR82","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s43018-023-00647-3","volume":"5","author":"J Encarnacion-Rosado","year":"2024","unstructured":"Encarnacion-Rosado J, et al. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism. Nat Cancer. 2024;5:85\u201399.","journal-title":"Nat Cancer"},{"key":"2520_CR83","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc.2016.114","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer. 2016;16:749.","journal-title":"Nat Rev Cancer"},{"key":"2520_CR84","doi-asserted-by":"publisher","first-page":"112154","DOI":"10.1016\/j.exger.2023.112154","volume":"175","author":"SH Naeini","year":"2023","unstructured":"Naeini SH, Mavaddatiyan L, Kalkhoran ZR, Taherkhani S, Talkhabi M. Alpha-ketoglutarate as a potent regulator for lifespan and healthspan: evidences and perspectives. Exp Gerontol. 2023;175:112154.","journal-title":"Exp Gerontol"},{"key":"2520_CR85","first-page":"1","volume":"51","author":"S Chang","year":"2019","unstructured":"Chang S, Yim S, Park H. The cancer driver genes IDH1\/2, JARID1C\/ KDM5C, and UTX\/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. Exp Mol Med. 2019;51:1\u201317.","journal-title":"Exp Mol Med"},{"key":"2520_CR86","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13072-023-00489-4","volume":"16","author":"R Dhat","year":"2023","unstructured":"Dhat R, et al. Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart. Epigenetics Chromatin. 2023;16:12.","journal-title":"Epigenetics Chromatin"},{"key":"2520_CR87","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son J, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013;496:101\u20135.","journal-title":"Nature"},{"key":"2520_CR88","doi-asserted-by":"crossref","unstructured":"Muir A et al. Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase Inhibition. Elife. 2017;6:e27713.","DOI":"10.7554\/eLife.27713"},{"key":"2520_CR89","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2015.447","volume":"35","author":"L Jin","year":"2016","unstructured":"Jin L, Alesi GN, Kang S. Glutaminolysis as a target for cancer therapy. Oncogene. 2016;35:3619\u201325.","journal-title":"Oncogene"},{"key":"2520_CR90","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2520_CR91","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.molcel.2025.04.018","volume":"85","author":"M Valverde-Santiago","year":"2025","unstructured":"Valverde-Santiago M, Pontel LB. Emerging mechanisms underlying formaldehyde toxicity and response. Mol Cell. 2025;85:2068\u201379.","journal-title":"Mol Cell"},{"key":"2520_CR92","doi-asserted-by":"publisher","first-page":"152650","DOI":"10.1016\/j.tox.2020.152650","volume":"448","author":"XN Li","year":"2021","unstructured":"Li XN, et al. Formaldehyde induces ferroptosis in hippocampal neuronal cells by upregulation of the Warburg effect. Toxicology. 2021;448:152650.","journal-title":"Toxicology"},{"key":"2520_CR93","doi-asserted-by":"publisher","first-page":"108902","DOI":"10.1016\/j.reprotox.2025.108902","volume":"134","author":"K Mao","year":"2025","unstructured":"Mao K, et al. The role of ATG7-mediated ferroptosis in formaldehyde-induced ovarian injury in rats. Reprod Toxicol. 2025;134:108902.","journal-title":"Reprod Toxicol"},{"key":"2520_CR94","doi-asserted-by":"publisher","first-page":"1570270","DOI":"10.3389\/fbioe.2025.1570270","volume":"13","author":"S Chen","year":"2025","unstructured":"Chen S, et al. Development and application of a stepwise-assembled modular biomimetic lung chip for analyzing formaldehyde-induced cellular ferroptosis. Front Bioeng Biotechnol. 2025;13:1570270.","journal-title":"Front Bioeng Biotechnol"},{"key":"2520_CR95","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.yjmcc.2025.07.010","volume":"206","author":"S Zhao","year":"2025","unstructured":"Zhao S, et al. LncRNA 91234.1 targets PRMT1\/ASCL4\/GPX4 axis to regulate formaldehyde-induced cardiomyocyte ferroptosis and congenital heart disease. J Mol Cell Cardiol. 2025;206:76\u201390.","journal-title":"J Mol Cell Cardiol"},{"key":"2520_CR96","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.freeradbiomed.2025.07.045","volume":"239","author":"Y Takami","year":"2025","unstructured":"Takami Y, et al. Systemic aldehyde storm induced by allyl alcohol exposure results in extensive hepatic ferroptosis in Aldh2\u22172 knock-in mice. Free Radic Biol Med. 2025;239:177\u201388.","journal-title":"Free Radic Biol Med"},{"key":"2520_CR97","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/S0021-9258(17)35926-4","volume":"261","author":"S Bannai","year":"1986","unstructured":"Bannai S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem. 1986;261:2256\u201363.","journal-title":"J Biol Chem"},{"key":"2520_CR98","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/ars.2011.4391","volume":"18","author":"J Lewerenz","year":"2013","unstructured":"Lewerenz J, et al. The cystine\/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18:522\u201355.","journal-title":"Antioxid Redox Signal"},{"key":"2520_CR99","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599\u2013620.","journal-title":"Protein Cell"},{"key":"2520_CR100","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1369\/jhc.5A6840.2006","volume":"54","author":"J Burdo","year":"2006","unstructured":"Burdo J, Dargusch R, Schubert D. Distribution of the cystine\/glutamate antiporter system xc- in the brain, kidney, and duodenum. J Histochem Cytochem. 2006;54:549\u201357.","journal-title":"J Histochem Cytochem"},{"key":"2520_CR101","doi-asserted-by":"publisher","first-page":"858462","DOI":"10.3389\/fonc.2022.858462","volume":"12","author":"N Jyotsana","year":"2022","unstructured":"Jyotsana N, Ta KT, DelGiorno KE. The role of Cystine\/Glutamate antiporter SLC7A11\/xCT in the pathophysiology of cancer. Front Oncol. 2022;12:858462.","journal-title":"Front Oncol"},{"key":"2520_CR102","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","volume":"31","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11\/xCT K11-linked ubiquitination and degradation. Cell Death Differ. 2024;31:53\u201364.","journal-title":"Cell Death Differ"},{"key":"2520_CR103","doi-asserted-by":"publisher","first-page":"2291855","DOI":"10.1080\/15384047.2023.2291855","volume":"25","author":"P Nath","year":"2024","unstructured":"Nath P, et al. The amino acid transporter SLC7A11 expression in breast cancer. Cancer Biol Ther. 2024;25:2291855.","journal-title":"Cancer Biol Ther"},{"key":"2520_CR104","doi-asserted-by":"publisher","first-page":"154646","DOI":"10.1016\/j.prp.2023.154646","volume":"248","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Cui J, Cui M, Jing R. SLC7A11 promotes the progression of gastric cancer and regulates ferroptosis through PI3K\/AKT pathway. Pathol Res Pract. 2023;248:154646.","journal-title":"Pathol Res Pract"},{"key":"2520_CR105","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1158\/0008-5472.CAN-23-0285","volume":"83","author":"R Sun","year":"2023","unstructured":"Sun R, et al. Androgen receptor variants confer castration resistance in prostate cancer by counteracting Antiandrogen-Induced ferroptosis. Cancer Res. 2023;83:3192\u2013204.","journal-title":"Cancer Res"},{"key":"2520_CR106","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"2520_CR107","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","volume":"79","author":"F He","year":"2023","unstructured":"He F, et al. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. J Hepatol. 2023;79:362\u201377.","journal-title":"J Hepatol"},{"key":"2520_CR108","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M de la Rojo","year":"2018","unstructured":"de la Rojo M, Chapman E, Zhang DD. NRF2 and the hallmarks of cancer. Cancer Cell. 2018;34:21\u201343.","journal-title":"Cancer Cell"},{"key":"2520_CR109","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-025-01145-0","volume":"24","author":"DD Zhang","year":"2025","unstructured":"Zhang DD. Thirty years of NRF2: advances and therapeutic challenges. Nat Rev Drug Discov. 2025;24:421\u201344.","journal-title":"Nat Rev Drug Discov"},{"key":"2520_CR110","doi-asserted-by":"crossref","unstructured":"Taguchi K, Yamamoto M. The KEAP1-NRF2 system as a molecular target of cancer treatment. Cancers (Basel). 2020;13(1):46.","DOI":"10.3390\/cancers13010046"},{"key":"2520_CR111","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1042\/bj20021619","volume":"371","author":"E Balogun","year":"2003","unstructured":"Balogun E, et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J. 2003;371:887\u201395.","journal-title":"Biochem J"},{"key":"2520_CR112","doi-asserted-by":"crossref","unstructured":"Campbell MR, et al. Novel hematopoietic target genes in the NRF2-mediated transcriptional pathway. Oxid Med Cell Longev. 2013;2013:120305.","DOI":"10.1155\/2013\/120305"},{"key":"2520_CR113","doi-asserted-by":"publisher","first-page":"e2305563","DOI":"10.1002\/advs.202305563","volume":"11","author":"H Wang","year":"2024","unstructured":"Wang H, et al. VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2\/HO-1 signaling pathway in diabetic nephropathy. Adv Sci (Weinh). 2024;11:e2305563.","journal-title":"Adv Sci (Weinh)"},{"key":"2520_CR114","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41419-021-04367-3","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, et al. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2\/HO-1 signalling pathway in KRAS mutant colorectal cancer. Cell Death Dis. 2021;12:1079.","journal-title":"Cell Death Dis"},{"key":"2520_CR115","doi-asserted-by":"publisher","first-page":"865689","DOI":"10.3389\/fphar.2022.865689","volume":"13","author":"W Yang","year":"2022","unstructured":"Yang W, et al. Maresin1 protect against Ferroptosis-Induced liver injury through ROS Inhibition and Nrf2\/HO-1\/GPX4 activation. Front Pharmacol. 2022;13:865689.","journal-title":"Front Pharmacol"},{"key":"2520_CR116","doi-asserted-by":"crossref","unstructured":"Qiang Z et al. Nrf2 and STAT3 Alleviates Ferroptosis-Mediated IIR-ALI by Regulating SLC7A11. Oxid Med Cell Longev. 2020;2020:5146982.","DOI":"10.1155\/2020\/5146982"},{"key":"2520_CR117","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mce.2017.02.014","volume":"451","author":"K Linher-Melville","year":"2017","unstructured":"Linher-Melville K, Singh G. The complex roles of STAT3 and STAT5 in maintaining redox balance: lessons from STAT-mediated xCT expression in cancer cells. Mol Cell Endocrinol. 2017;451:40\u201352.","journal-title":"Mol Cell Endocrinol"},{"key":"2520_CR118","doi-asserted-by":"publisher","first-page":"155282","DOI":"10.1016\/j.phymed.2023.155282","volume":"124","author":"X Deng","year":"2024","unstructured":"Deng X, Lin B, Wang F, Xu P, Wang N. Mangiferin attenuates osteoporosis by inhibiting osteoblastic ferroptosis through Keap1\/Nrf2\/SLC7A11\/GPX4 pathway. Phytomedicine. 2024;124:155282.","journal-title":"Phytomedicine"},{"key":"2520_CR119","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57\u201362.","journal-title":"Nature"},{"key":"2520_CR120","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang L, et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc(). Cell Death Differ. 2020;27:662\u201375.","journal-title":"Cell Death Differ"},{"key":"2520_CR121","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181\u201392.","journal-title":"Nat Cell Biol"},{"key":"2520_CR122","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41419-022-05344-0","volume":"13","author":"M Yang","year":"2022","unstructured":"Yang M, et al. Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis. Cell Death Dis. 2022;13:912.","journal-title":"Cell Death Dis"},{"key":"2520_CR123","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","volume":"19","author":"T Ishimoto","year":"2011","unstructured":"Ishimoto T, et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell. 2011;19:387\u2013400.","journal-title":"Cancer Cell"},{"key":"2520_CR124","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","volume":"79","author":"T Liu","year":"2019","unstructured":"Liu T, Jiang L, Tavana O, Gu W. The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11. Cancer Res. 2019;79:1913\u201324.","journal-title":"Cancer Res"},{"key":"2520_CR125","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1074\/jbc.RA119.012213","volume":"295","author":"I Yamaguchi","year":"2020","unstructured":"Yamaguchi I, Yoshimura SH, Katoh H. High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine\/glutamate transporter xCT (SLC7A11). J Biol Chem. 2020;295:6936\u201345.","journal-title":"J Biol Chem"},{"key":"2520_CR126","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.molcel.2017.05.030","volume":"67","author":"Y Gu","year":"2017","unstructured":"Gu Y, et al. mTORC2 regulates amino acid metabolism in cancer by phosphorylation of the Cystine-Glutamate antiporter xCT. Mol Cell. 2017;67:128\u2013e138127.","journal-title":"Mol Cell"},{"key":"2520_CR127","doi-asserted-by":"crossref","unstructured":"Lien EC, Ghisolfi L, Geck RC, Asara JM, Toker A. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT. Sci Signal. 2017;10(510):eaao6604.","DOI":"10.1126\/scisignal.aao6604"},{"key":"2520_CR128","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1158\/0008-5472.CAN-15-2121","volume":"76","author":"K Tsuchihashi","year":"2016","unstructured":"Tsuchihashi K, et al. The EGF receptor promotes the malignant potential of glioma by regulating amino acid transport system xc(-). Cancer Res. 2016;76:2954\u201363.","journal-title":"Cancer Res"},{"key":"2520_CR129","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3109\/10715769109093424","volume":"14","author":"R Schuckelt","year":"1991","unstructured":"Schuckelt R, et al. Phospholipid hydroperoxide glutathione peroxidase is a Selenoenzyme distinct from the classical glutathione peroxidase as evident from cDNA and amino acid sequencing. Free Radic Res Commun. 1991;14:343\u201361.","journal-title":"Free Radic Res Commun"},{"key":"2520_CR130","doi-asserted-by":"publisher","first-page":"188890","DOI":"10.1016\/j.bbcan.2023.188890","volume":"1878","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W. GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment. Biochim Biophys Acta Rev Cancer. 2023;1878:188890.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2520_CR131","doi-asserted-by":"crossref","unstructured":"Peng JJ, Yue SY, Fang YH, Liu XL, Wang CH. Mechanisms affecting the biosynthesis and incorporation rate of selenocysteine. Molecules. 2021;26(23):7120.","DOI":"10.3390\/molecules26237120"},{"key":"2520_CR132","doi-asserted-by":"publisher","first-page":"18923","DOI":"10.1073\/pnas.0609703104","volume":"103","author":"J Yuan","year":"2006","unstructured":"Yuan J, et al. RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea. Proc Natl Acad Sci U S A. 2006;103:18923\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2520_CR133","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0076-6879(02)47020-6","volume":"347","author":"A Roveri","year":"2002","unstructured":"Roveri A, Flohe L, Maiorino M, Ursini F. Phospholipid-hydroperoxide glutathione peroxidase in sperm. Methods Enzymol. 2002;347:208\u201312.","journal-title":"Methods Enzymol"},{"key":"2520_CR134","doi-asserted-by":"crossref","unstructured":"Weaver K, Skouta R. The Selenoprotein glutathione peroxidase 4: from molecular mechanisms to novel therapeutic opportunities. Biomedicines 2022;10(4):891.","DOI":"10.3390\/biomedicines10040891"},{"key":"2520_CR135","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347\u201364.","journal-title":"Cell Res"},{"key":"2520_CR136","doi-asserted-by":"publisher","first-page":"e2118646119","DOI":"10.1073\/pnas.2118646119","volume":"119","author":"GC Forcina","year":"2022","unstructured":"Forcina GC, et al. Ferroptosis regulation by the NGLY1\/NFE2L1 pathway. Proc Natl Acad Sci U S A. 2022;119:e2118646119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2520_CR137","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.7150\/thno.55482","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, et al. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma. Theranostics. 2021;11:5650\u201374.","journal-title":"Theranostics"},{"key":"2520_CR138","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mc.23527","volume":"62","author":"J Chen","year":"2023","unstructured":"Chen J, et al. AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP\/SLC7A11 signaling pathway. Mol Carcinog. 2023;62:833\u201344.","journal-title":"Mol Carcinog"},{"key":"2520_CR139","doi-asserted-by":"publisher","first-page":"1110146","DOI":"10.3389\/fphar.2023.1110146","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, et al. Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR\/GPX4 axis activated ferroptosis. Front Pharmacol. 2023;14:1110146.","journal-title":"Front Pharmacol"},{"key":"2520_CR140","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y, Kang R, Klionsky DJ, Tang D. GPX4 in cell death, autophagy, and disease. Autophagy. 2023;19:2621\u201338.","journal-title":"Autophagy"},{"key":"2520_CR141","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1111\/cas.13701","volume":"109","author":"MJ Kerins","year":"2018","unstructured":"Kerins MJ, Milligan J, Wohlschlegel JA, Ooi A. Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction. Cancer Sci. 2018;109:2757\u201366.","journal-title":"Cancer Sci"},{"key":"2520_CR142","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41594-018-0084-y","volume":"25","author":"V Akimov","year":"2018","unstructured":"Akimov V, et al. UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018;25:631\u201340.","journal-title":"Nat Struct Mol Biol"},{"key":"2520_CR143","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41467-020-14324-x","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang Y, et al. Nedd4 ubiquitylates VDAC2\/3 to suppress erastin-induced ferroptosis in melanoma. Nat Commun. 2020;11:433.","journal-title":"Nat Commun"},{"key":"2520_CR144","doi-asserted-by":"publisher","first-page":"115393","DOI":"10.1016\/j.ejmech.2023.115393","volume":"255","author":"C Zheng","year":"2023","unstructured":"Zheng C, et al. Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization. Eur J Med Chem. 2023;255:115393.","journal-title":"Eur J Med Chem"},{"key":"2520_CR145","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586\u201390.","journal-title":"Nature"},{"key":"2520_CR146","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou Y, et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun. 2019;10:1617.","journal-title":"Nat Commun"},{"key":"2520_CR147","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138.","journal-title":"Nature"},{"key":"2520_CR148","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392.","journal-title":"Nature"},{"key":"2520_CR149","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima E, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022;608:778\u201383.","journal-title":"Nature"},{"key":"2520_CR150","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/nutrit\/nuab061","volume":"80","author":"P Mladenka","year":"2022","unstructured":"Mladenka P, et al. Vitamin K - sources, physiological role, kinetics, deficiency, detection, therapeutic use, and toxicity. Nutr Rev. 2022;80:677\u201398.","journal-title":"Nutr Rev"},{"key":"2520_CR151","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1021\/acschembio.2c00028","volume":"17","author":"H Yoshioka","year":"2022","unstructured":"Yoshioka H, et al. Identification of a small molecule that enhances ferroptosis via Inhibition of ferroptosis suppressor protein 1 (FSP1). ACS Chem Biol. 2022;17:483\u201391.","journal-title":"ACS Chem Biol"},{"key":"2520_CR152","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-cellbio-100616-060600","volume":"34","author":"J McCullough","year":"2018","unstructured":"McCullough J, Frost A, Sundquist WI, Structures. Functions, and dynamics of ESCRT-III\/Vps4 membrane remodeling and fission complexes. Annu Rev Cell Dev Biol. 2018;34:85\u2013109.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2520_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41417-020-0200-0","volume":"28","author":"J Liu","year":"2021","unstructured":"Liu J, Kang R, Tang D. ESCRT-III-mediated membrane repair in cell death and tumor resistance. Cancer Gene Ther. 2021;28:1\u20134.","journal-title":"Cancer Gene Ther"},{"key":"2520_CR154","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2022;13:2206.","journal-title":"Nat Commun"},{"key":"2520_CR155","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41418-022-01096-8","volume":"30","author":"F Muller","year":"2023","unstructured":"Muller F, et al. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death Differ. 2023;30:442\u201356.","journal-title":"Cell Death Differ"},{"key":"2520_CR156","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmgh.2023.03.001","volume":"16","author":"JW Cheu","year":"2023","unstructured":"Cheu JW, et al. Ferroptosis suppressor protein 1 Inhibition promotes tumor ferroptosis and Anti-tumor immune responses in liver cancer. Cell Mol Gastroenterol Hepatol. 2023;16:133\u201359.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2520_CR157","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","volume":"619","author":"T Nakamura","year":"2023","unstructured":"Nakamura T, et al. Phase separation of FSP1 promotes ferroptosis. Nature. 2023;619:371\u20137.","journal-title":"Nature"},{"key":"2520_CR158","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88.","journal-title":"Cell Death Dis"},{"key":"2520_CR159","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13046-022-02296-3","volume":"41","author":"JK Byun","year":"2022","unstructured":"Byun JK, et al. Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41:98.","journal-title":"J Exp Clin Cancer Res"},{"key":"2520_CR160","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41375-022-01573-6","volume":"36","author":"B Pardieu","year":"2022","unstructured":"Pardieu B, et al. Cystine uptake Inhibition potentiates front-line therapies in acute myeloid leukemia. Leukemia. 2022;36:1585\u201395.","journal-title":"Leukemia"},{"key":"2520_CR161","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1038\/s41401-024-01336-2","volume":"45","author":"X Jiang","year":"2024","unstructured":"Jiang X, et al. The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy. Acta Pharmacol Sin. 2024;45:2229\u201340.","journal-title":"Acta Pharmacol Sin"},{"key":"2520_CR162","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12951-023-01998-w","volume":"21","author":"Z Rao","year":"2023","unstructured":"Rao Z, et al. Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination. J Nanobiotechnol. 2023;21:265.","journal-title":"J Nanobiotechnol"},{"key":"2520_CR163","doi-asserted-by":"publisher","first-page":"103660","DOI":"10.1016\/j.redox.2025.103660","volume":"83","author":"Y Ju","year":"2025","unstructured":"Ju Y, et al. Protein S-glutathionylation confers cellular resistance to ferroptosis induced by glutathione depletion. Redox Biol. 2025;83:103660.","journal-title":"Redox Biol"},{"key":"2520_CR164","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"J Guo","year":"2018","unstructured":"Guo J, et al. Ferroptosis: A novel Anti-tumor action for cisplatin. Cancer Res Treat. 2018;50:445\u201360.","journal-title":"Cancer Res Treat"},{"key":"2520_CR165","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2024.05.013","volume":"221","author":"F Zhang","year":"2024","unstructured":"Zhang F, et al. Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts. Free Radic Biol Med. 2024;221:23\u201330.","journal-title":"Free Radic Biol Med"},{"key":"2520_CR166","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nchembio.2079","volume":"12","author":"K Shimada","year":"2016","unstructured":"Shimada K, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol. 2016;12:497\u2013503.","journal-title":"Nat Chem Biol"},{"key":"2520_CR167","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10616-024-00619-0","volume":"76","author":"Y Sheng","year":"2024","unstructured":"Sheng Y, et al. The effect of TFAP2A\/ANXA8 axis on ferroptosis of cervical squamous cell carcinoma (CESC) in vitro. Cytotechnology. 2024;76:403\u201314.","journal-title":"Cytotechnology"},{"key":"2520_CR168","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331.","journal-title":"Cell"},{"key":"2520_CR169","doi-asserted-by":"publisher","first-page":"53501","DOI":"10.1021\/acsami.2c15495","volume":"14","author":"LP Zhao","year":"2022","unstructured":"Zhao LP, et al. Photodynamic therapy initiated ferrotherapy of Self-Delivery nanomedicine to amplify lipid peroxidation via GPX4 inactivation. ACS Appl Mater Interfaces. 2022;14:53501\u201310.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2520_CR170","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","volume":"16","author":"JK Eaton","year":"2020","unstructured":"Eaton JK, et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat Chem Biol. 2020;16:497\u2013506.","journal-title":"Nat Chem Biol"},{"key":"2520_CR171","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cell.2015.05.056","volume":"162","author":"JH Woo","year":"2015","unstructured":"Woo JH, et al. Elucidating compound mechanism of action by network perturbation analysis. Cell. 2015;162:441\u201351.","journal-title":"Cell"},{"key":"2520_CR172","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jare.2023.08.018","volume":"62","author":"LP Zhao","year":"2024","unstructured":"Zhao LP, et al. \u03b2-Elemene induced ferroptosis via TFEB-mediated GPX4 degradation in EGFR wide-type non-small cell lung cancer. J Adv Res. 2024;62:257\u201372.","journal-title":"J Adv Res"},{"key":"2520_CR173","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12951-021-01058-1","volume":"19","author":"X Yao","year":"2021","unstructured":"Yao X, et al. Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J Nanobiotechnol. 2021;19:311.","journal-title":"J Nanobiotechnol"},{"key":"2520_CR174","doi-asserted-by":"publisher","first-page":"10448","DOI":"10.1007\/s12035-024-04216-2","volume":"61","author":"H Shi","year":"2024","unstructured":"Shi H, et al. Edaravone alleviates traumatic brain injury by Inhibition of ferroptosis via FSP1 pathway. Mol Neurobiol. 2024;61:10448\u201361.","journal-title":"Mol Neurobiol"},{"key":"2520_CR175","doi-asserted-by":"publisher","first-page":"e2505197122","DOI":"10.1073\/pnas.2505197122","volume":"122","author":"S Zhang","year":"2025","unstructured":"Zhang S, et al. Cocrystal structure reveals the mechanism of FSP1 Inhibition by FSEN1. Proc Natl Acad Sci U S A. 2025;122:e2505197122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2520_CR176","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","volume":"642","author":"T Ca\u00f1eque","year":"2025","unstructured":"Ca\u00f1eque T, et al. Activation of lysosomal iron triggers ferroptosis in cancer. Nature. 2025;642:492\u2013500.","journal-title":"Nature"},{"key":"2520_CR177","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","volume":"14","author":"MM Gaschler","year":"2018","unstructured":"Gaschler MM, et al. FINO(2) initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018;14:507\u201315.","journal-title":"Nat Chem Biol"},{"key":"2520_CR178","doi-asserted-by":"publisher","first-page":"124142","DOI":"10.1016\/j.saa.2024.124142","volume":"313","author":"A Blat","year":"2024","unstructured":"Blat A, et al. Human erythrocytes under stress. Spectroscopic fingerprints of known oxidative mechanisms and beyond. Spectrochim Acta Mol Biomol Spectrosc. 2024;313:124142.","journal-title":"Spectrochim Acta Mol Biomol Spectrosc"},{"key":"2520_CR179","doi-asserted-by":"publisher","first-page":"122489","DOI":"10.1016\/j.carbpol.2024.122489","volume":"343","author":"J Shi","year":"2024","unstructured":"Shi J, et al. Self-assembled hyaluronic acid nanomicelle for enhanced cascade cancer chemotherapy via self-sensitized ferroptosis. Carbohydr Polym. 2024;343:122489.","journal-title":"Carbohydr Polym"},{"key":"2520_CR180","first-page":"23","volume":"13","author":"R Zhang","year":"2022","unstructured":"Zhang R, et al. Curcumenol triggered ferroptosis in lung cancer cells via LncRNA H19\/miR-19b-3p\/FTH1 axis. Bioact Mater. 2022;13:23\u201336.","journal-title":"Bioact Mater"},{"key":"2520_CR181","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/1535-7163.MCT-21-0728","volume":"21","author":"J Li","year":"2022","unstructured":"Li J, et al. Small-Molecule MMRi62 induces ferroptosis and inhibits metastasis in pancreatic cancer via degradation of ferritin heavy chain and mutant p53. Mol Cancer Ther. 2022;21:535\u201345.","journal-title":"Mol Cancer Ther"},{"key":"2520_CR182","doi-asserted-by":"publisher","unstructured":"Mao C, Jiang D, Koong AC, Gan B. Exploiting metabolic cell death for cancer therapy. Nat Rev Cancer. 2025.\u00a0https:\/\/doi.org\/10.1038\/s41568-025-00879-8.","DOI":"10.1038\/s41568-025-00879-8"},{"key":"2520_CR183","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","journal-title":"Science"},{"key":"2520_CR184","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.tibs.2024.04.002","volume":"49","author":"CH Lin","year":"2024","unstructured":"Lin CH, et al. Protein lipoylation: mitochondria, cuproptosis, and beyond. Trends Biochem Sci. 2024;49:729\u201344.","journal-title":"Trends Biochem Sci"},{"key":"2520_CR185","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41589-022-01159-4","volume":"19","author":"V Schulz","year":"2023","unstructured":"Schulz V, et al. Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nat Chem Biol. 2023;19:206\u201317.","journal-title":"Nat Chem Biol"},{"key":"2520_CR186","doi-asserted-by":"publisher","first-page":"105046","DOI":"10.1016\/j.jbc.2023.105046","volume":"299","author":"MB Dreishpoon","year":"2023","unstructured":"Dreishpoon MB, et al. FDX1 regulates cellular protein lipoylation through direct binding to LIAS. J Biol Chem. 2023;299:105046.","journal-title":"J Biol Chem"},{"key":"2520_CR187","doi-asserted-by":"publisher","first-page":"e70080","DOI":"10.1002\/jsp2.70080","volume":"8","author":"Z Li","year":"2025","unstructured":"Li Z, Wang L, Wu X, Huang R, Yuan Y. Crosstalk between ferroptosis and Cuproptosis in intervertebral disc degeneration: Mechanisms, therapeutic Targets, and future directions. JOR Spine. 2025;8:e70080.","journal-title":"JOR Spine"},{"key":"2520_CR188","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.cell.2024.04.037","volume":"187","author":"A Suomalainen","year":"2024","unstructured":"Suomalainen A, Nunnari J. Mitochondria at the crossroads of health and disease. Cell. 2024;187:2601\u201327.","journal-title":"Cell"},{"key":"2520_CR189","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMB, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Res. 2018;28:265\u201380.","journal-title":"Cell Res"},{"key":"2520_CR190","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2024.07.006","volume":"223","author":"X Song","year":"2024","unstructured":"Song X, Hao X, Zhu BT. Role of mitochondrial reactive oxygen species in chemically-induced ferroptosis. Free Radic Biol Med. 2024;223:473\u201392.","journal-title":"Free Radic Biol Med"},{"key":"2520_CR191","doi-asserted-by":"publisher","first-page":"102164","DOI":"10.1016\/j.redox.2021.102164","volume":"47","author":"AD Read","year":"2021","unstructured":"Read AD, Bentley RE, Archer SL, Dunham-Snary KJ. Mitochondrial iron-sulfur clusters: Structure, function, and an emerging role in vascular biology. Redox Biol. 2021;47:102164.","journal-title":"Redox Biol"},{"key":"2520_CR192","doi-asserted-by":"crossref","unstructured":"Gan B. Mitochondrial regulation of ferroptosis. J Cell Biol. 2021;220(9):e202105043.","DOI":"10.1083\/jcb.202105043"},{"key":"2520_CR193","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, et al. Role of mitochondria in ferroptosis. Mol Cell. 2019;73:354\u2013e363353.","journal-title":"Mol Cell"},{"key":"2520_CR194","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy. 2023;19:1982\u201396.","journal-title":"Autophagy"},{"key":"2520_CR195","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P. Vanden Berghe, T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35:830\u201349.","journal-title":"Cancer Cell"},{"key":"2520_CR196","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9:55.","journal-title":"Signal Transduct Target Ther"},{"key":"2520_CR197","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"2520_CR198","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, et al. Ferroptosis as a potential target for cancer therapy. Cell Death Dis. 2023;14:460.","journal-title":"Cell Death Dis"},{"key":"2520_CR199","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1002\/jcp.29232","volume":"235","author":"X Zhang","year":"2020","unstructured":"Zhang X, et al. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin. J Cell Physiol. 2020;235:3425\u201337.","journal-title":"J Cell Physiol"},{"key":"2520_CR200","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.neo.2021.11.002","volume":"23","author":"W Huang","year":"2021","unstructured":"Huang W, et al. ABCC5 facilitates the acquired resistance of Sorafenib through the Inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma. Neoplasia. 2021;23:1227\u201339.","journal-title":"Neoplasia"},{"key":"2520_CR201","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41419-021-03718-4","volume":"12","author":"Q Wang","year":"2021","unstructured":"Wang Q, et al. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via Inhibition of NRF2\/GPX4 axis. Cell Death Dis. 2021;12:426.","journal-title":"Cell Death Dis"},{"key":"2520_CR202","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan HF, et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6:49.","journal-title":"Signal Transduct Target Ther"},{"key":"2520_CR203","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","volume":"30","author":"J Kim","year":"2019","unstructured":"Kim J, DeBerardinis RJ. Mechanisms and implications of metabolic heterogeneity in cancer. Cell Metab. 2019;30:434\u201346.","journal-title":"Cell Metab"},{"key":"2520_CR204","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 Inhibition. Nature. 2017;551:247\u201350.","journal-title":"Nature"},{"key":"2520_CR205","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","volume":"27","author":"FM Howard","year":"2021","unstructured":"Howard FM, Olopade OI. Epidemiology of Triple-Negative breast cancer: A review. Cancer J. 2021;27:8\u201316.","journal-title":"Cancer J"},{"key":"2520_CR206","doi-asserted-by":"crossref","unstructured":"Gupta GK, et al. Perspectives on Triple-Negative breast cancer: current treatment Strategies, unmet Needs, and potential targets for future therapies. Cancers (Basel). 2020;12(9):2392.","DOI":"10.3390\/cancers12092392"},{"key":"2520_CR207","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s11655-021-3458-7","volume":"28","author":"XD Liu","year":"2022","unstructured":"Liu XD, Song CY, Kong CC, Tian X. Bufalin induces programmed necroptosis in Triple-Negative breast cancer Drug-Resistant cell lines through RIP1\/ROS-Mediated pathway. Chin J Integr Med. 2022;28:900\u20138.","journal-title":"Chin J Integr Med"},{"key":"2520_CR208","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/08923973.2023.2165943","volume":"45","author":"J Wang","year":"2023","unstructured":"Wang J, Li Y, Zhang J, Luo C. Isoliquiritin modulates ferroptosis via NF-kappaB signaling Inhibition and alleviates doxorubicin resistance in breast cancer. Immunopharmacol Immunotoxicol. 2023;45:443\u201354.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2520_CR209","doi-asserted-by":"publisher","first-page":"837974","DOI":"10.3389\/fonc.2022.837974","volume":"12","author":"C Sun","year":"2022","unstructured":"Sun C, Liu P, Pei L, Zhao M, Huang Y. Propofol inhibits proliferation and augments the Anti-Tumor effect of doxorubicin and Paclitaxel partly through promoting ferroptosis in Triple-Negative breast cancer cells. Front Oncol. 2022;12:837974.","journal-title":"Front Oncol"},{"key":"2520_CR210","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.21037\/tlcr-21-303","volume":"10","author":"T Zhang","year":"2021","unstructured":"Zhang T, et al. Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma. Transl Lung Cancer Res. 2021;10:1857\u201372.","journal-title":"Transl Lung Cancer Res"},{"key":"2520_CR211","doi-asserted-by":"publisher","first-page":"101928","DOI":"10.1016\/j.redox.2021.101928","volume":"42","author":"T Hong","year":"2021","unstructured":"Hong T, et al. PARP Inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer. Redox Biol. 2021;42:101928.","journal-title":"Redox Biol"},{"key":"2520_CR212","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41420-023-01385-2","volume":"9","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, et al. ACSL1-induced ferroptosis and platinum resistance in ovarian cancer by increasing FSP1 N-myristylation and stability. Cell Death Discov. 2023;9:83.","journal-title":"Cell Death Discov"},{"key":"2520_CR213","doi-asserted-by":"crossref","unstructured":"Lee J, Roh JL. Unleashing ferroptosis in human cancers: targeting ferroptosis suppressor protein 1 for overcoming therapy resistance. Antioxid (Basel). 2023;12(6):1218.","DOI":"10.3390\/antiox12061218"},{"key":"2520_CR214","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 2019;9:1673\u201385.","journal-title":"Cancer Discov"},{"key":"2520_CR215","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41419-020-03209-y","volume":"11","author":"S Adjemian","year":"2020","unstructured":"Adjemian S, et al. Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death. Cell Death Dis. 2020;11:1003.","journal-title":"Cell Death Dis"},{"key":"2520_CR216","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei G, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020;30:146\u201362.","journal-title":"Cell Res"},{"key":"2520_CR217","doi-asserted-by":"publisher","first-page":"1216733","DOI":"10.3389\/fmolb.2023.1216733","volume":"10","author":"GL Beretta","year":"2023","unstructured":"Beretta GL, Zaffaroni N. Radiotherapy-induced ferroptosis for cancer treatment. Front Mol Biosci. 2023;10:1216733.","journal-title":"Front Mol Biosci"},{"key":"2520_CR218","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2011.12.012","volume":"327","author":"EI Azzam","year":"2012","unstructured":"Azzam EI, Jay-Gerin JP, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 2012;327:48\u201360.","journal-title":"Cancer Lett"},{"key":"2520_CR219","doi-asserted-by":"crossref","unstructured":"Kerkhove L, Geirnaert F, Dufait I, De Ridder M. Ferroptosis: Frenemy of Radiotherapy. Int J Mol Sci. 2024;25(7):3641.","DOI":"10.3390\/ijms25073641"},{"key":"2520_CR220","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1021\/acschembio.9b00939","volume":"15","author":"LF Ye","year":"2020","unstructured":"Ye LF, et al. Radiation-Induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chem Biol. 2020;15:469\u201384.","journal-title":"ACS Chem Biol"},{"key":"2520_CR221","doi-asserted-by":"publisher","first-page":"1085581","DOI":"10.3389\/fonc.2023.1085581","volume":"13","author":"Z Lu","year":"2023","unstructured":"Lu Z, et al. The potential of ferroptosis combined with radiotherapy in cancer treatment. Front Oncol. 2023;13:1085581.","journal-title":"Front Oncol"},{"key":"2520_CR222","doi-asserted-by":"publisher","first-page":"101576","DOI":"10.1016\/j.tranon.2022.101576","volume":"27","author":"WM Huang","year":"2023","unstructured":"Huang WM, et al. m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis. Transl Oncol. 2023;27:101576.","journal-title":"Transl Oncol"},{"key":"2520_CR223","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen Q, et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ. 2023;30:137\u201351.","journal-title":"Cell Death Differ"},{"key":"2520_CR224","doi-asserted-by":"publisher","first-page":"215919","DOI":"10.1016\/j.canlet.2022.215919","volume":"550","author":"D Shen","year":"2022","unstructured":"Shen D, et al. PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer. Cancer Lett. 2022;550:215919.","journal-title":"Cancer Lett"},{"key":"2520_CR225","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","volume":"25","author":"M Roerden","year":"2025","unstructured":"Roerden M, Spranger S. Cancer immune evasion, immunoediting and intratumour heterogeneity. Nat Rev Immunol. 2025;25:353\u201369.","journal-title":"Nat Rev Immunol"},{"key":"2520_CR226","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33:1001\u2013e10121005.","journal-title":"Cell Metab"},{"key":"2520_CR227","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim R, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612:338\u201346.","journal-title":"Nature"},{"key":"2520_CR228","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3350\/cmh.2024.0948","volume":"31","author":"Y Qin","year":"2025","unstructured":"Qin Y, et al. CD36 promotes iron accumulation and dysfunction in CD8\u2009+\u2009T cells via the p38-CEBPB-TfR1 axis in earlystage hepatocellular carcinoma. Clin Mol Hepatol. 2025;31:960\u201380.","journal-title":"Clin Mol Hepatol"},{"key":"2520_CR229","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41421-024-00682-z","volume":"10","author":"S Li","year":"2024","unstructured":"Li S, et al. DEPDC5 protects CD8(+) T cells from ferroptosis by limiting mTORC1-mediated purine catabolism. Cell Discov. 2024;10:53.","journal-title":"Cell Discov"},{"key":"2520_CR230","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/CM9.0000000000002989","volume":"137","author":"X Pan","year":"2024","unstructured":"Pan X, Wang J, Zhang L, Li G, Huang B. Metabolic plasticity of T cell fate decision. Chin Med J (Engl). 2024;137:762\u201375.","journal-title":"Chin Med J (Engl)"},{"key":"2520_CR231","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","volume":"620","author":"C Guo","year":"2023","unstructured":"Guo C, et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature. 2023;620:200\u20138.","journal-title":"Nature"},{"key":"2520_CR232","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.03.004","volume":"31","author":"H Kurniawan","year":"2020","unstructured":"Kurniawan H, et al. Glutathione restricts Serine metabolism to preserve regulatory T cell function. Cell Metab. 2020;31:920\u2013e936927.","journal-title":"Cell Metab"},{"key":"2520_CR233","doi-asserted-by":"publisher","first-page":"1648432","DOI":"10.3389\/fimmu.2025.1648432","volume":"16","author":"W Wang","year":"2025","unstructured":"Wang W, et al. Bridging the gap: ferroptosis of immune cells in the tumor microenvironment. Front Immunol. 2025;16:1648432.","journal-title":"Front Immunol"},{"key":"2520_CR234","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/imcb.70027","volume":"103","author":"N Valentini","year":"2025","unstructured":"Valentini N, Cier R, C.J., Lamarche C. Highlights of 2024: Tregs immunometabolism and how to counter inflammatory niches. Immunol Cell Biol. 2025;103:504\u20138.","journal-title":"Immunol Cell Biol"},{"key":"2520_CR235","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1038\/s41467-025-59307-y","volume":"16","author":"D Teng","year":"2025","unstructured":"Teng D, et al. DHODH modulates immune evasion of cancer cells via CDP-Choline dependent regulation of phospholipid metabolism and ferroptosis. Nat Commun. 2025;16:3867.","journal-title":"Nat Commun"},{"key":"2520_CR236","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137.","journal-title":"Nature"},{"key":"2520_CR237","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","volume":"33","author":"E Dierge","year":"2021","unstructured":"Dierge E, et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021;33:1701\u201315. e1705.","journal-title":"Cell Metab"},{"key":"2520_CR238","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270\u20134.","journal-title":"Nature"},{"key":"2520_CR239","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40:365\u2013e378366.","journal-title":"Cancer Cell"},{"key":"2520_CR240","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1080\/15548627.2020.1714209","volume":"16","author":"E Dai","year":"2020","unstructured":"Dai E, et al. Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy. 2020;16:2069\u201383.","journal-title":"Autophagy"},{"key":"2520_CR241","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1080\/15548627.2021.2008692","volume":"18","author":"J Liu","year":"2022","unstructured":"Liu J, et al. DCN released from ferroptotic cells ignites AGER-dependent immune responses. Autophagy. 2022;18:2036\u201349.","journal-title":"Autophagy"},{"key":"2520_CR242","doi-asserted-by":"publisher","first-page":"e2301928","DOI":"10.1002\/advs.202301928","volume":"10","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, et al. PGAM1 Inhibition promotes HCC ferroptosis and synergizes with Anti-PD-1 immunotherapy. Adv Sci (Weinh). 2023;10:e2301928.","journal-title":"Adv Sci (Weinh)"},{"key":"2520_CR243","doi-asserted-by":"publisher","first-page":"102463","DOI":"10.1016\/j.redox.2022.102463","volume":"56","author":"X Hao","year":"2022","unstructured":"Hao X, et al. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 2022;56:102463.","journal-title":"Redox Biol"},{"key":"2520_CR244","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/CAD.0000000000001573","volume":"35","author":"L Mei","year":"2024","unstructured":"Mei L, et al. APOC1 reduced anti-PD-1 immunotherapy of nonsmall cell lung cancer via the transformation of M2 into M1 macrophages by ferroptosis by NRF2\/HO-1. Anticancer Drugs. 2024;35:333\u201343.","journal-title":"Anticancer Drugs"},{"key":"2520_CR245","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2015.07.031","volume":"368","author":"MZ Ma","year":"2015","unstructured":"Ma MZ, et al. Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism. Cancer Lett. 2015;368:88\u201396.","journal-title":"Cancer Lett"},{"key":"2520_CR246","doi-asserted-by":"publisher","first-page":"7765","DOI":"10.1021\/jacs.4c17661","volume":"147","author":"VS Khodade","year":"2025","unstructured":"Khodade VS, et al. Thiol-Activated donors of hydropersulfides which are excreted to maintain cellular redox homeostasis or retained to counter oxidative stress. J Am Chem Soc. 2025;147:7765\u201376. Arylsulfonothioates.","journal-title":"J Am Chem Soc"},{"key":"2520_CR247","doi-asserted-by":"publisher","first-page":"e202412585","DOI":"10.1002\/anie.202412585","volume":"63","author":"N Montesdeoca","year":"2024","unstructured":"Montesdeoca N, Johannknecht L, Efanova E, Heinen-Weiler J, Karges J. Ferroptosis inducing Co(III) polypyridine sulfasalazine complex for therapeutically enhanced anticancer therapy. Angew Chem Int Ed Engl. 2024;63:e202412585.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2520_CR248","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pharmthera.2011.01.005","volume":"130","author":"KE Miller","year":"2011","unstructured":"Miller KE, Hoffman EM, Sutharshan M, Schechter R. Glutamate Pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms. Pharmacol Ther. 2011;130:283\u2013309.","journal-title":"Pharmacol Ther"},{"key":"2520_CR249","doi-asserted-by":"publisher","first-page":"101250","DOI":"10.1016\/j.drup.2025.101250","volume":"81","author":"J He","year":"2025","unstructured":"He J, et al. Targeting SLC7A11 with Sorafenib sensitizes stereotactic body radiotherapy in colorectal cancer liver metastasis. Drug Resist Updat. 2025;81:101250.","journal-title":"Drug Resist Updat"},{"key":"2520_CR250","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41467-021-21841-w","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021;12:1589.","journal-title":"Nat Commun"},{"key":"2520_CR251","doi-asserted-by":"publisher","first-page":"e2100997","DOI":"10.1002\/advs.202100997","volume":"8","author":"X Yao","year":"2021","unstructured":"Yao X, et al. Emerging roles of energy metabolism in ferroptosis regulation of tumor cells. Adv Sci (Weinh). 2021;8:e2100997.","journal-title":"Adv Sci (Weinh)"},{"key":"2520_CR252","doi-asserted-by":"publisher","first-page":"115774","DOI":"10.1016\/j.celrep.2025.115774","volume":"44","author":"Y Chen","year":"2025","unstructured":"Chen Y, et al. GCLM lactylation mediated by ACAT2 promotes ferroptosis resistance in KRAS(G12D)-mutant cancer. Cell Rep. 2025;44:115774.","journal-title":"Cell Rep"},{"key":"2520_CR253","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-023-02925-5","volume":"43","author":"Y Hua","year":"2024","unstructured":"Hua Y, et al. Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment. J Exp Clin Cancer Res. 2024;43:19.","journal-title":"J Exp Clin Cancer Res"},{"key":"2520_CR254","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1038\/s41388-021-01676-x","volume":"40","author":"CC Lin","year":"2021","unstructured":"Lin CC, et al. DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway. Oncogene. 2021;40:2018\u201334.","journal-title":"Oncogene"},{"key":"2520_CR255","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1021\/acs.jmedchem.3c01749","volume":"67","author":"TM Shi","year":"2024","unstructured":"Shi TM, Chen XF, Ti H. Ferroptosis-Based therapeutic strategies toward precision medicine for cancer. J Med Chem. 2024;67:2238\u201363.","journal-title":"J Med Chem"},{"key":"2520_CR256","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbrc.2016.10.068","volume":"480","author":"X Song","year":"2016","unstructured":"Song X, et al. FANCD2 protects against bone marrow injury from ferroptosis. Biochem Biophys Res Commun. 2016;480:443\u20139.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02520-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:03:51Z","timestamp":1764590631000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02520-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":256,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2520"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02520-6","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"303"}}